NEW YORK – The European Commission on Wednesday approved Amgen's bi-specific T-cell engager Blincyto (blinatumomab) as part of consolidation therapy for the treatment of adult patients with newly ...
The European Commission (EC) has approved Blincyto (blinatumomab) monotherapy as part of consolidation therapy for the treatment of adults with newly-diagnosed Philadelphia chromosome-negative ...
The camp will end with the exhibition match involving Filipinas players to be held at the newly-completed MOA Football Field, a rare opportunity for the Filipino fans to watch the team at home.
while preserving the heritage and cultural elements,” Loke said after witnessing the signing of a signing of a memorandum of agreement (MoA) on the project between Ipoh Sentral Sdn Bhd (ISSB ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results